STONEPINE CAPITAL, L.P. purchased 0.2% of their position (9.70K shares) of NOVELION THERAPEUTICS INC. on the open market
Open‑market purchase worth $6.8K — a small addition. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 12/9/2019ACC: 0001567619-19-022780
10% Owner
Since Sep 2019
+9.70K
Net shares
Net buyer
$6.8K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
9.70K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+5.16K
Price / share
$0.70
Trade value
$3.61K
% of position
0.1%
12/5/2019
3.89M→3.90M
Common Stock
Direct
Shares
+40.00
Price / share
$0.70
Trade value
$28.00
% of position
0.0%
12/6/2019
3.90M→3.90M
Common Stock
Direct
Shares
+4.50K
Price / share
$0.70
Trade value
$3.15K
% of position
0.1%
12/9/2019
3.90M→3.90M
Total
Net shares
+9.70K
Net value
$6.79K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/5/2019 | P · Purchase | +5.16K | $0.70 | $3.61K | 0.1% | 3.89M | 3.90M |
| Common Stock Direct | 12/6/2019 | P · Purchase | +40.00 | $0.70 | $28.00 | 0.0% | 3.90M | 3.90M |
| Common Stock Direct | 12/9/2019 | P · Purchase | +4.50K | $0.70 | $3.15K | 0.1% | 3.90M | 3.90M |
| Total | +9.70K | $6.79K | ||||||
Derivative Transactions0
No derivative transactions reported